Experimental evaluation of the activity of the product meflochine against coronavirus SАRS-CoV-2

Filin KN1, Berzin IA2, Bykov VN1, Gladkikh VD1, Loginova SYa3, Savenko SV3, Schukina VN3
About authors

1 Federal State Unitary Enterprise Research & Production Center "Pharmaceutical Protection" of Federal Medical Biological Agency, Khimki, Russia

2 Federal Medical and Biological Agency, Moscow, Russia

3 Federal State Budgetary Institution "48 Central Research Institute" of the Ministry of Defense of the Russian Federation, Sergiev Posad-6, Russia

Received: 2020-06-25 Accepted: 2020-07-17 Published online: 2020-08-09
Table 1.
Table 2.
Table 3.